CVS Health Expands GLP-1 Support for Patients

Dow Jones06-22

By Connor Hart

CVS Health will expand support for patients using GLP-1 medications, including lower-cost access programs, pharmacist support and over-the-counter products aimed at managing common side effects.

The company said Monday it will begin participating in the Centers for Medicare & Medicaid Services' Medicare GLP-1 Bridge program, effective July 1. The program will help address cost concerns, allowing eligible Medicare beneficiaries to obtain certain GLP-1 medications for $50 a month through Dec. 31, 2027.

For those not eligible for the program, CVS noted it accepts several third-party prescription discount cards, manufacturer coupons and manufacturer vouchers to help reduce out-of-pocket costs.

CVS will additionally launch a new digital health offering, a $49 virtual MinuteClinic visit that can connect eligible adults with licensed clinicians for weight-loss evaluations and, when appropriate, prescriptions for GLP-1 drugs.

The service will be available in 47 states and Washington, D.C., designed for adults between the ages of 18 and 64 who are overweight and intend to pay out-of-pocket for clinical weight-loss services.

Write to Connor Hart at connor.hart@wsj.com

(END) Dow Jones Newswires

June 22, 2026 09:10 ET (13:10 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2645274670?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-22 21:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2645274670","market":"hk","top_or_hot":-1,"title":"CVS Health Expands GLP-1 Support for Patients","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Connor Hart \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  CVS Health will expand support for patients using GLP-1 medications, including lower-cost access programs, pharmacist support and over-the-counter products aimed at managing common side effects. \n</p>\n<p>\n  The company said Monday it will begin participating in the Centers for Medicare &amp; Medicaid Services' Medicare GLP-1 Bridge program, effective July 1. The program will help address cost concerns, allowing eligible Medicare beneficiaries to obtain certain GLP-1 medications for $50 a month through Dec. 31, 2027. \n</p>\n<p>\n  For those not eligible for the program, CVS noted it accepts several third-party prescription discount cards, manufacturer coupons and manufacturer vouchers to help reduce out-of-pocket costs. \n</p>\n<p>\n  CVS will additionally launch a new digital health offering, a $49 virtual MinuteClinic visit that can connect eligible adults with licensed clinicians for weight-loss evaluations and, when appropriate, prescriptions for GLP-1 drugs. \n</p>\n<p>\n  The service will be available in 47 states and Washington, D.C., designed for adults between the ages of 18 and 64 who are overweight and intend to pay out-of-pocket for clinical weight-loss services. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 22, 2026 09:10 ET (13:10 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CVS Health Expands GLP-1 Support for Patients</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCVS Health Expands GLP-1 Support for Patients\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-06-22 21:10</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Connor Hart \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  CVS Health will expand support for patients using GLP-1 medications, including lower-cost access programs, pharmacist support and over-the-counter products aimed at managing common side effects. \n</p>\n<p>\n  The company said Monday it will begin participating in the Centers for Medicare &amp; Medicaid Services' Medicare GLP-1 Bridge program, effective July 1. The program will help address cost concerns, allowing eligible Medicare beneficiaries to obtain certain GLP-1 medications for $50 a month through Dec. 31, 2027. \n</p>\n<p>\n  For those not eligible for the program, CVS noted it accepts several third-party prescription discount cards, manufacturer coupons and manufacturer vouchers to help reduce out-of-pocket costs. \n</p>\n<p>\n  CVS will additionally launch a new digital health offering, a $49 virtual MinuteClinic visit that can connect eligible adults with licensed clinicians for weight-loss evaluations and, when appropriate, prescriptions for GLP-1 drugs. \n</p>\n<p>\n  The service will be available in 47 states and Washington, D.C., designed for adults between the ages of 18 and 64 who are overweight and intend to pay out-of-pocket for clinical weight-loss services. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 22, 2026 09:10 ET (13:10 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0162691827.USD","symbol_name":"BGF US BASIC VALUE \"A4\" INC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2645274670","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2645274670","pubTimestamp":1782133800,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"CVS Health will expand support for patients using GLP-1 medications, including lower-cost access programs, pharmacist support and over-the-counter products aimed at managing common side effects.The company said Monday it will begin participating in the Centers for Medicare & Medicaid Services' Medicare GLP-1 Bridge program, effective July 1. The program will help address cost concerns, allowing eligible Medicare beneficiaries to obtain certain GLP-1 medications for $50 a month through Dec. 31, 2027.For those not eligible for the program, CVS noted it accepts several third-party prescription discount cards, manufacturer coupons and manufacturer vouchers to help reduce out-of-pocket costs.CVS will additionally launch a new digital health offering, a $49 virtual MinuteClinic visit that can connect eligible adults with licensed clinicians for weight-loss evaluations and, when appropriate, prescriptions for GLP-1 drugs.The service will be available in 47 states and Washington, D.C., designe","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC","CVS":"西维斯健康","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU0072461881.USD":"BGF US BASIC VALUE \"A2\" ACC","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","BK4196":"保健护理服务","BK4581":"高盛持仓","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","BK4144":"石油与天然气的储存和运输","BK4590":"PTP","BK4585":"ETF&股票定投概念","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","GLP":"Global Partners Lp","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","LU1699723380.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"AP\" (USD) ACC","LU1923622614.USD":"Natixis Thematics Meta R/A USD","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU2125909593.SGD":"Natixis Thematics Meta R/A SGD","BK4504":"桥水持仓","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","BK4550":"红杉资本持仓","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","BK4588":"碎股","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC"},"translate_title":"CVS Health扩大对患者的GLP-1支持","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GLP":1.5,"CVS":1.5},"content_text":"By Connor Hart \n\n\n \n\n\n  CVS Health will expand support for patients using GLP-1 medications, including lower-cost access programs, pharmacist support and over-the-counter products aimed at managing common side effects. \n\n\n  The company said Monday it will begin participating in the Centers for Medicare & Medicaid Services' Medicare GLP-1 Bridge program, effective July 1. The program will help address cost concerns, allowing eligible Medicare beneficiaries to obtain certain GLP-1 medications for $50 a month through Dec. 31, 2027. \n\n\n  For those not eligible for the program, CVS noted it accepts several third-party prescription discount cards, manufacturer coupons and manufacturer vouchers to help reduce out-of-pocket costs. \n\n\n  CVS will additionally launch a new digital health offering, a $49 virtual MinuteClinic visit that can connect eligible adults with licensed clinicians for weight-loss evaluations and, when appropriate, prescriptions for GLP-1 drugs. \n\n\n  The service will be available in 47 states and Washington, D.C., designed for adults between the ages of 18 and 64 who are overweight and intend to pay out-of-pocket for clinical weight-loss services. \n\n\n \n\n\n  Write to Connor Hart at connor.hart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 22, 2026 09:10 ET (13:10 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2645274670","isCrawlerRequest":true}